ChromaDex Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

For the Six Month Period Ended July 2, 2016

Previously
Reported

Adjustments

As Adjusted

Cash Flows From Operating Activities

Net income

$

172,958

$

—

$

172,958

Adjustments to reconcile net income to net cash used in operating activities:

1,011,158

281,092

1,292,250

Changes in operating assets and liabilities:

(4,171,503

)

—

(4,171,503

)

Net cash used in operating activities

(2,987,387

)

281,092

(2,706,295

)

Cash Flows From Investing Activities

Purchases of leasehold improvements and equipment

(231,201

)

—

(231,201

)

Purchases of intangible assets

(195,000

)

—

(195,000

)

Net cash used in investing activities

(426,201

)

—

(426,201

)

Cash Flows From Financing Activities

Proceeds from issuance of common stock, net of issuance costs

5,720,000

—

5,720,000

Proceeds from exercise of stock options

622,384

—

622,384

Principal payments on loan payable

(5,000,000

)

—

(5,000,000

)

Cash paid for debt extinguishment costs

—

(281,092

)

(281,092

)

Principal payments on capital leases

(108,249

)

—

(108,249

)

Net cash provided by financing activities

1,234,135

(281,092

)

953,043

Net decrease in cash

(2,179,453

)

—

(2,179,453

)

Cash Beginning of Period

5,549,672

—

5,549,672

Cash Ending of Period

$

3,370,219

$

—

$

3,370,219